Clinical trial
A Single-Arm Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants With Advanced Lung Cancer
NCT07673419 is registered in ClinicalTrials.gov with Beijing Geekgene Technology Co., LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Arm Clinical Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GK01 Cell Injection in Participants With Advanced Lung Cancer
- Lead sponsor
- Beijing Geekgene Technology Co., LTD
- Phase
- Phase 1
- Overall status
- Not yet recruiting
- Start date
- July 31, 2026
- Completion date
- July 31, 2028
- Enrollment
- 10 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
advanced lung cancer